NCT04473794Recruiting
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Source: ClinicalTrials.gov · Last updated 2 Mar 2026
Brief summary (registry, in English)
The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 8 Jul 2020
- Start date
- 20 Jul 2022
- Primary completion date
- 1 Nov 2035
- Lead sponsor
- Johns Hopkins University
- Diseases
- Pancreatic cancer
- NCT number
- NCT04473794
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 20 Jul 2022 to the primary completion date, 1 Nov 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Medically ill patients with American Society of Anesthesiologists class 4 or greater.
- Inability to provide informed consent.
- Pregnancy or lactation.
Who the study is looking for
- Adult patients age 18 years and older
- Referred for assessment of a pancreatic cyst.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Johns Hopkins Hospital Coordinator of this site? Confirm its status | Baltimore | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.